Early cholesterol check for newborns of parents with lipid disorder
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This study tests whether checking a newborn's blood spot for a genetic condition that causes very high cholesterol can help detect it early. It may help families understand their baby's risk and start care sooner if needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your partner must be at least 18 years old.
- You or your partner must be diagnosed with familial hypercholesterolemia (a genetic condition that causes very high cholesterol).
- You are currently pregnant and your baby is at least 12 weeks along (about 3 months).
- You are willing to have your baby's blood tested after birth using a simple heel prick.
- You and your baby live in the United States.
- Your baby has no serious medical conditions that would interfere with the blood test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at children who may have inherited high cholesterol, especially when one parent is affected. It may help doctors detect the condition earlier and understand how it runs in families.
This study checks children ages 1 to 3 during routine care to see who may have familial hypercholesterolemia, a genetic condition that causes high cholesterol. Early identification can help families learn about next steps and prevention.
This study aims to find and help people with very high cholesterol, which can run in families. If you or your child have high cholesterol, this study may help you understand your risk and get the right care.
This study tests a digital screening method to help identify and diagnose familial hypercholesterolemia, an inherited condition that can cause very high cholesterol. If you participate, you may be invited to complete screening steps to see whether they can find the condition early.
This trial focuses on people referred to a cholesterol (lipid) clinic to help identify inherited high cholesterol. It tests an “interpretive comment” approach to nudge detection—meaning it may help clinicians recognize who is most likely to have familial hypercholesterolemia.
This trial focuses on people with familial hypercholesterolemia (FH), an inherited condition that causes very high cholesterol. It aims to better understand and manage severe cholesterol problems that raise heart risk, especially in families.
Hear when a new Heterozygous Familial Hypercholesterolemia (HeFH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.